Loading stock data…
CNMD
$35.84-0.96 (-2.61%)
Market OpenUpdated 3:09 PM EDT
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CONMED Corporation in the Healthcare sector is trading at $35.84. The stock is currently near its 52-week low of $33.21, remaining 18.6% below its 200-day moving average. Technical signals show neutral RSI of 32 and bearish MACD signal, explaining why CNMD maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 32) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$35.84
Potential Downside
21%
Whystock Fair Value$28.31
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Hold
Mean target$42.00+17.2%
Range$39.00 – $52.00
Fundamentals
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
25.49
Beta
Defensive asset. Lower volatility than the S&P 500.
0.99
Div Yield
Strong income play. Yield provides a meaningful total return floor.
209.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.67%
Volume
Today's trading volume
304,420
Recent News
Is CONMED Corporation (CNMD) A Good Stock To Buy Now?
Is CNMD a good stock to buy? We came across a bullish thesis on CONMED Corporation on Valueinvestorsclub.com by anton613. In this article, we will summarize the bulls’ thesis on CNMD. CONMED Corporation’s share was trading at $36.79 as of April 28th. CNMD’s trailing P/E was 25.08 according to Yahoo Finance. Conmed Corporation (CNMD) is a medical […]
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 1.3% year on year to $317 million. The company expects the full year’s revenue to be around $1.36 billion, close to analysts’ estimates. Its non-GAAP profit of $0.89 per share was 8.8% above analysts’ consensus estimates.
CONMED Corporation Q1 2026 Earnings Call Summary
Moby summary of CONMED Corporation's Q1 2026 earnings call
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up
CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on higher-growth segments.
Conmed Corp (CNMD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Capitalizing on ...
Despite a slight dip in total sales, Conmed Corp (CNMD) focuses on strategic growth areas like orthopedics and smoke evacuation, while addressing inflationary pressures and debt refinancing.